Advertisement

Topics

Former Akamai CEO Paul Sagan Joins Moderna’s Board of Directors

16:00 EDT 14 Jun 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Moderna Therapeutics, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Paul Sagan has join...

Other Sources for this Article

Moderna Contacts:
Investors:
Lorence Kim
617-209-5849
Lorence.kim@modernatx.com
or
Media:
Jason Glashow
617-674-5648
Jason.glashow@modernatx.com

NEXT ARTICLE

More From BioPortfolio on "Former Akamai CEO Paul Sagan Joins Moderna’s Board of Directors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...